Analyst Reco. argenx SE

Equities

ARGX

NL0010832176

Biotechnology & Medical Research

Real-time Euronext Bruxelles Other stock markets 10:09:24 13/01/2026 GMT			5-day change	1st Jan Change
696.60 ^EUR	+3.69%		+1.90%	-2.82%

09:00am	ARGENX : Jefferies reaffirms its Buy rating	ZD
08:48am	Argenx Says it Gets US FDA's Acceptance for Priority Review for Vyvgart sBLA	MT

Analyst Reco.

09:00am	ARGENX : Jefferies reaffirms its Buy rating	ZD
01-12	ARGENX : Receives a Buy rating from DZ Bank	ZD
12-22	DZ Bank Research Initiates Argenx Coverage with Buy Rating	MT
12-18	Argenx Shares Fall After Baird Downgrade	MT
12-18	Baird Downgrades argenx to Neutral From Outperform, Adjusts Price Target to $858 From $924	MT
12-17	RBC Raises Price Target on argenx to $925 From $860, Keeps Outperform Rating	MT
12-16	ARGENX : Gets a Buy rating from Bernstein	ZD
12-15	ARGENX : Gets a Buy rating from Jefferies	ZD
12-15	ARGENX : Goldman Sachs gives a Buy rating	ZD
12-15	ARGENX : UBS is Neutral	ZD
12-15	ARGENX : JP Morgan reaffirms its Buy rating	ZD
12-04	KBC Securities Upgrades Argenx to Buy, Boosts PT	MT
11-24	Wolfe Research Downgrades argenx to Peer Perform From Outperform	MT
11-14	Wedbush Raises Price Target on argenx to $1,000 From $880, Keeps Outperform Rating	MT
13/10/25	Wedbush Raises Price Target on argenx to $880 From $800, Keeps Outperform Rating	MT
01/10/25	Argenx's Broader Pipeline Value Underappreciated, Morgan Stanley Says	MT
01/10/25	Morgan Stanley Raises Price Target on Argenx to $1,040 From $766, Keeps Overweight Rating	MT
12/09/25	The stock market regains its cloak of invincibility
26/08/25	William O'Neil & Co Begins Argenx Coverage at Buy	MT
25/08/25	Argenx's Vyvgart Uptake is Likely to Accelerate, RBC Says	MT
25/08/25	Bank Degroof Petercam Raises Argenx PT, Maintains at Buy	MT
25/08/25	RBC Initiates Argenx at Outperform With $850 Price Target	MT
01/08/25	Morgan Stanley Raises Price Target on argenx SE to $766 From $700, Keeps Overweight Rating	MT
08/07/25	Deutsche Bank Upgrades Argenx to Buy, Raises PT	MT
13/05/25	Baird Upgrades argenx to Outperform From Neutral, Price Target is $680	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Analyst Reco. argenx SE

Equities

ARGX

NL0010832176

Biotechnology & Medical Research

Analyst Reco.

Filters